BRAENDER LORI J
Corporate Secretary
BRAENDER LORI J has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 11, 2026.
On the most recent filing, BRAENDER LORI J is listed as Chief Legal Officer at Aquestive Therapeutics, Inc. Inside the rolling window, BRAENDER LORI J reported no open-market purchases and 1 open-market sale totaling $167K in AQST.
Companies traded
Other insiders at AQST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$167K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BRAENDER LORI J made?
BRAENDER LORI J has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does BRAENDER LORI J trade?
BRAENDER LORI J has filed SEC Form 4 disclosures for 1 company, including AQST.
When was BRAENDER LORI J's most recent SEC Form 4 filing?
BRAENDER LORI J's most recent SEC Form 4 filing on Tracefour is dated May 11, 2026.
What is BRAENDER LORI J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BRAENDER LORI J is listed as Corporate Secretary.
What is BRAENDER LORI J's total buy and sell value in the current window?
Inside the rolling retention window, BRAENDER LORI J bought $0 and sold $167K based on SEC Form 4 filings.
What was BRAENDER LORI J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 40,102 AQST shares on 2026-03-10, worth $167K, per SEC Form 4 filings.